SAN DIEGO--Sequenom announced that it will install its MassArray genotyping system as the platform for the high-throughput haplotyping facility at Genaissance Pharmaceuticals, a population genomics and informatics company in New Haven, Conn. The agreement follows an initial MassArray system placement at Genaissance, which will now purchase at least two additional units.
Sequenom to Establish MassArray Haplotyping Facility at Genaissance
May 18, 2000
Premium